awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q45055095-88EE808D-CC7A-4FFC-8F26-73FE899B9538
Q45055095-88EE808D-CC7A-4FFC-8F26-73FE899B9538
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45055095-88EE808D-CC7A-4FFC-8F26-73FE899B9538
Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.
P2860
Q45055095-88EE808D-CC7A-4FFC-8F26-73FE899B9538
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45055095-88EE808D-CC7A-4FFC-8F26-73FE899B9538
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
061195d8ab1a980e1c53dbbde97634e792f2b9d8
P2860
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515.